Pan-antiviral peptides for protein kinase inhibition
View Patent ↗A method of inhibiting protein kinases by administering polypeptides derived from alpha-neurotoxin, and inhibiting protein kinases. Diseases treated thereby include cancer, influenza, Tourette's syndrome, pain, and neurological deficits.
1. A method of treating Tourette's syndrome comprising:
administering to a patient in need thereof an effective amount of a pharmaceutical composition comprising a polypeptide derived from alpha-neurotoxin,
wherein the polypeptide derived from alpha-neurotoxin is prepared by reduction and alkylation of disulfide bonds.
2. The method of claim 1 , wherein the pharmaceutical composition is an injectable formulation.
3. The method of claim 1 , wherein the route of administration is injection.
4. The method of claim 3 , wherein the pharmaceutical composition is administered once daily.
5. The method of claim 1 , wherein the administration reduces tics and speech impediments.